We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go: Expired investment: £1,314,967
Novus aspires to become the UK's first ethical digital bank. It argues that Generation Z and millennials want purpose-driven products and services that can also address environmental and social challenges of the times. The company asserts that its services align with the aforementioned objective. Novus allows its members to live a sustainable lifestyle by providing them access to sustainable brands through Novus' in-app marketplace and rewarding them via cashbacks. The company intends to undergo two more funding rounds – Series A and Series B – for scaling its UK operations and expanding in the US and other key EU markets within the next two years. It will IPO its business when it achieves profitability. The company also foresees a strategic exit to interested banking entities.
days to go: Expired investment: £732,000
Nudjed is the only company in the world to specialise in the collection and analysis of ‘Health Intention Data’, helping tailor approaches to behavioural change. Nudjed has a working product and has sold annual contracts to several large organisations (NHS x 3, Public Health Wales, GoCompare, Bridgend Council). We plan to continue development of behavioural change tools and expand our revenues in public and workforce health, whilst exploring opportunities in health insurance.
days to go: Expired investment: £174,999
OpenPlay is a marketplace for sports facilities and activities. It makes it easier for the public to find and book local venues and activities. It has a social layer on top to connect people to each other around their sporting interests and abilities. It makes money via a mixture of a subscription (SAAS) and commission based model for the use of its online bookings and customer management tools. We already have 80,000+ monthly visitors, 100,000+ bookings and over 2,000 venues listed.
days to go: Expired investment: £75,000
Orbitil have created a fun and easy project management program for comparing analytics and business intelligence. They provide a large variety of tools to help business leaders make better tactical decisions based on confirmed data. 
days to go: Expired investment: £133,414
Ordoo believes that in 3 years everyone will order food and drink via digital channels. They’re determined to transform the way we order by creating exceptional mobile ordering experiences. As a result, Ordoo has built a mobile ordering app that saves busy people time ordering food and drink. Ordoo plans to lead the transformation to digital ordering and help our partner venues increase their profitable sales. Their mobile ordering platform has proven to increase customer frequency by 3x/month, average spend by 13% and encourage word of mouth referrals. Since launching in January 2016, they’ve processed 35k+ orders, signed up 19k+ users and partnered with 75+ venues in 3 cities.
days to go: Expired investment: £50,000
OSS will develop a range of innovative baby products using cutting-edge space and other smart technologies. Over the last 10 years childcare equipments have gone through limited innovations with outdated technologies. Existing baby travel cots and travel systems are complicated to deploy and heavy. SpaceCot is a lightweight baby cot (5kg) which can be deployed within seconds. It is developed based on satellite technologies from European Space Agency.
days to go: Expired investment: £202,825
Oxford Space Structures have used rocket science to build a travel cot based on space technology. This travel cot is lightweight and safe and has been designed to allow families to travel more without worrying about sleeping arrangments for their babies.
days to go: Expired investment: £199,880
Perfect World Ice Cream is a healthy indulgent treat which is good for you. They have less sugar, less calories and real fruit and vegetable purees which provide health benefits. They have created a range of family friendly flavours and are available in stores such as Holland & Barratt, Tescos and Ocado. 
days to go: Expired investment: £147,360
PIE Mapping (PIE) is an expert provider of mapping and journey planning solutions and a leading player in the fast growing $15 billion Intelligent Transportation System (“ITS”) market. The company provide up-to-the-minute mapping datasets and downloads for routing and software manufacturers based on the PIE Data Exchange offering and platform. We operate the Freight Journey Planner for TfL which is evolving into a B to B national model with a wide array of Smart City Road routing applications.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph